Taken together, our results show that oxaliplatin mediates differential cellular responses in colon cancer cells depending on their p53 status, and demonstrate that the ROS-p53 axis is important for regulating POU3F2 and its downstream target, tNOX, in this system. This evidence concerns the gene TP53 and malignant colon neoplasm.